“…The final decision of whether to return to bypass is one made by the surgeon, upon consideration of the full information available from the intraoperative team. TEE has been reported to identify problems needing a return to bypass for further surgery in about 3-8% of bypass cases [6][7][8]12,13,17,18,20,21,[23][24][25]27,[66][67][68][69][70]75,94,99,101,110,118,119]. With a return to bypass rate in this range, the routine use of TEE during repair of congenital heart malformations is cost-effective [82,83,100,101,120,121].…”